Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMX-101 photoallergy study in healthy volunteers
NCT04070755Phase 1Completed
- Sponsor
- Vyne Therapeutics
- Start
- Sep 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of minocycline in acne vulgaris, sponsored by Vyne Therapeutics. Primary endpoint: Assessment of photoallergic skin reactions at 6 weeks. Started Sep 2016; status: completed.
02
Drugs
minocycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04070755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04070755.